EONS 2019 | Totally Implantable Vascular Access Device (TIVAD) service for patients with metastatic cancer

Matthew Fowler

Matthew Fowler, BScN, MSc, Heart of England NHS Foundation Trust, Birmingham, UK, discusses the benefits of the introduction of a nurse-led Totally Implantable Vascular Access Device (TIVAD) service for patients with metastatic cancer. This interview took place at EONS 12 during the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain. CN34 –

Share this video  
Similar topics